×

This article on Epainassist.com has been reviewed by a medical professional, as well as checked for facts, to assure the readers the best possible accuracy.

We follow a strict editorial policy and we have a zero-tolerance policy regarding any level of plagiarism. Our articles are resourced from reputable online pages. This article may contains scientific references. The numbers in the parentheses (1, 2, 3) are clickable links to peer-reviewed scientific papers.

The feedback link “Was this Article Helpful” on this page can be used to report content that is not accurate, up-to-date or questionable in any manner.

This article does not provide medical advice.

1

Toradol for Migraine Relief : Efficacy, Mechanism, and Potential Side Effects

What is Migraine?

Migraines are more than just severe headaches. They are a neurological disorder characterized by debilitating, often one-sided head pain that can last for days. These pains, typically pulsating in nature, can disrupt daily activities significantly.(1,2) What differentiates migraines from standard headaches are symptoms like nausea, sensitivity to light and sound, and visual disturbances termed ‘auras’.(3) Various triggers, such as specific foods and stress, initiate migraines, which involve intricate brain interactions and alterations in blood flow. Migraines severely affect an individual’s quality of life. While typical treatments include ibuprofen and aspirin, Toradol emerges as an effective alternative when traditional medications don’t suffice.

What is Toradol and is it Effective in Migraine Pain Relief?

Toradol, or ketorolac tromethamine, is a nonsteroidal anti-inflammatory drug (NSAID) commonly used for pain management. It is available in both injectable and oral forms. Toradol is often used to alleviate moderate to severe pain, such as that caused by surgery, injury, or certain medical conditions.(4)

In the context of migraines, Toradol may be administered as an injection to help treat moderate to severe migraine pain. It is typically given in healthcare settings, like a hospital or clinic. In some cases, a doctor may also prescribe Toradol in oral tablet form for the patient to take after the injection. However, oral Toradol should not be used for more than five days.(5)

Toradol has received approval from the Food and Drug Administration (FDA) for the treatment of moderately severe short-term pain. However, it is also utilized off-label for the management of migraine pain. Off-label drug use refers to the practice of using a medication that has been FDA-approved for one purpose to address a different condition or purpose that has not received specific FDA approval. Nevertheless, healthcare professionals have the discretion to prescribe medications for off-label uses, as the FDA primarily oversees the testing and approval of drugs rather than dictating how doctors apply them in their clinical practice.(6,7)

The effectiveness of Toradol in migraine pain relief can vary from person to person. It is considered an option when other medications like ibuprofen, diclofenac, naproxen, or aspirin do not provide adequate relief. Toradol works by reducing inflammation and blocking pain signals in the body.

It is important to note that Toradol is not without risks and potential side effects, especially when used for an extended period. Long-term use of NSAIDs like Toradol can lead to gastrointestinal problems and may increase the risk of cardiovascular events. Therefore, it should be used under the guidance of a healthcare professional, and the potential benefits and risks should be carefully considered on a case-by-case basis. If you experience frequent or severe migraines, it is essential to consult with a healthcare provider for proper diagnosis and a suitable treatment plan.

How Does Toradol Work to Reduce Migraine Pain?

Toradol works to reduce migraine pain through its action as a nonsteroidal anti-inflammatory drug (NSAID). While the precise mechanisms of migraine development are complex and not fully understood, NSAIDs like Toradol are believed to be effective in managing migraine pain due to their anti-inflammatory and analgesic (pain-relieving) properties.(8)

Here’s how Toradol may work to alleviate migraine pain:(9)

  • Having Anti-Inflammatory Action: Migraines are often associated with inflammation of blood vessels in the brain. Toradol can help reduce inflammation by inhibiting enzymes called cyclooxygenases (COX) that are involved in the production of inflammatory prostaglandins.(10)
  • Providing Pain Relief by Blocking Pain Signals: Toradol blocks pain signals in the body by reducing the production of prostaglandins, which are not only involved in inflammation but also play a role in transmitting pain signals to the brain.
  • By Causing Vasoconstriction: In some cases, Toradol may also cause constriction (narrowing) of blood vessels, which can be beneficial during a migraine. Migraines are thought to involve blood vessel dilation followed by constriction, and Toradol’s vasoconstrictive effect may help normalize blood vessel function.(11)

It is important to note that while Toradol may provide relief for some people with migraines, its effectiveness can vary. Additionally, Toradol is typically used in healthcare settings, such as hospitals or clinics, for acute migraine attacks when other treatments have not been successful. Long-term or frequent use of Toradol for migraines may not be recommended due to the potential for side effects and risks associated with NSAIDs. It should be used under the guidance of a healthcare provider, and those with migraines are encouraged to explore a comprehensive migraine management plan tailored to their specific needs.

Are There Any Side Effects to Taking Toradol?

Like all medications, Toradol can also have certain side effects. Some of the common and less common side effects of Toradol may include:

Gastrointestinal Effects:(12)

Kidney Effects:(13)

  • Impaired kidney function (especially with prolonged use or in certain individuals)

Cardiovascular Effects:(14)

  • Increased blood pressure
  • Fluid retention

Central Nervous System Effects:

Allergic Reactions:

  • Skin rash or itching
  • Swelling of the face, lips, or tongue
  • Difficulty breathing (anaphylaxis, rare but serious)

Hematologic Effects:

  • Risk of bleeding, including gastrointestinal bleeding
  • Decreased platelet function (increased bleeding risk)

Injection Site Reactions (for injectable forms):

  • Pain or discomfort at the injection site
  • Redness or swelling

It is important to note that while Toradol can be effective for pain relief, it should be used with caution and under the guidance of a healthcare provider. Long-term or frequent use of Toradol is generally discouraged due to the increased risk of side effects, especially in the gastrointestinal and renal (kidney) areas. Patients should be monitored for any adverse reactions, and the lowest effective dose for the shortest duration should be prescribed.

People taking Toradol or considering its use should discuss the potential benefits and risks with their healthcare provider, especially if they have a history of gastrointestinal problems, kidney issues, or allergies to NSAIDs. People who have recently undergone a surgery should also not take Toradol without consulting their doctor. In some cases, alternative treatments may be considered to minimize side effects.

Conclusion

The use of Toradol in migraine pain relief is a potential option for those people who experience moderate to severe migraine attacks. While Toradol, as a nonsteroidal anti-inflammatory drug (NSAID), can effectively address pain and inflammation associated with migraines, its usage should be approached with careful consideration of its potential side effects and risks, especially with prolonged or frequent use. It is typically reserved for acute migraine episodes when other treatments have proven ineffective, and its administration should be under the guidance of a healthcare provider. A comprehensive migraine management plan, individualized to a patient’s specific needs, may include Toradol as one component, with an emphasis on monitoring for adverse effects and exploring alternative therapies to ensure the best possible outcome in the management of this challenging condition.

References:

  1. Goadsby, P.J., Lipton, R.B. and Ferrari, M.D., 2002. Migraine—current understanding and treatment. New England journal of medicine, 346(4), pp.257-270.
  2. Pietrobon, D. and Moskowitz, M.A., 2013. Pathophysiology of migraine. Annual review of physiology, 75, pp.365-391.
  3. Rasmussen, B.K. and Olesen, J., 1992. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia, 12(4), pp.221-228.
  4. Spickler, W., 1993. Ketorolac (Toradol): a new analgesic or an old NSAID?. CMAJ: Canadian Medical Association Journal, 148(10), p.1693.
  5. Taggart, E., Doran, S., Kokotillo, A., Campbell, S., Villa‐Roel, C. and Rowe, B.H., 2013. Ketorolac in the treatment of acute migraine: a systematic review. Headache: The Journal of Head and Face Pain, 53(2), pp.277-287.
  6. Roberts, J.R., 2018. InFocus: The Best Three Treatments for Migraine. Emergency Medicine News, 40(1), pp.12-14.
  7. Drug approval package (no date) Ketorolac Tromethamine NDA# 74-754. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/74754_Ketorolac.cfm (Accessed: 05 September 2023).
  8. Mahmoodi, A.N. and Kim, P.Y., 2019. Ketorolac.
  9. Pardutz, A. and Schoenen, J., 2010. NSAIDs in the acute treatment of migraine: a review of clinical and experimental data. Pharmaceuticals, 3(6), pp.1966-1987.
  10. FitzGerald, G.A. and Patrono, C., 2001. The coxibs, selective inhibitors of cyclooxygenase-2. New England Journal of Medicine, 345(6), pp.433-442.
  11. Moskowitz, M.A. and Buzzi, M.G., 1991. Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions. Journal of neurology, 238, pp.S18-S22.
  12. Laine, L., 2003. Gastrointestinal effects of NSAIDs and coxibs. Journal of Pain and Symptom Management, 25(2), pp.32-40.
  13. Ejaz, P., Bhojani, K. and Joshi, V.R., 2004. NSAIDs and kidney. Japi, 52(632-640), p.371.
  14. Marsico, F., Paolillo, S. and Filardi, P.P., 2017. NSAIDs and cardiovascular risk. Journal of cardiovascular medicine, 18, pp.e40-e43.
Team PainAssist
Team PainAssist
Written, Edited or Reviewed By: Team PainAssist, Pain Assist Inc. This article does not provide medical advice. See disclaimer
Last Modified On:September 24, 2023

Recent Posts

Related Posts